Pharma Invest SPA has signed a cooperation agreement with the Chinese firm Yangtze River Pharmaceutical Group. The signing ceremony, overseen by the Minister of Pharmaceutical Industry in the presence of Saidal’s General Manager, aims to facilitate the transfer of technology and expertise for the local manufacturing of raw materials and the development of innovative drugs. The meeting also addressed potential future collaboration between Saidal and Pharma Invest in the production and distribution of high-value medications. The Minister expressed support for the deal, noting its importance in upgrading local industrial capabilities and advancing national health sovereignty.